| http://www.w3.org/ns/prov#value | - Amgen signs $1 billion cancer biotech dealhttp://www.inpharm.com/news/110125/amgen-biovex-cancer-dealAmgen is set to pay $1 billion for US biotech firm BioVex, in the process gaining access to its novel cancer vaccine OncoVEXGM-CSF.OncoVEXGM-CSF is a first-in-class oncolytic vaccine candidate designed to treat melanoma and other solid tumours as well as treating genital warts.Amgen, the world???s
|
